IRLAB Therapeutics and the McQuade Center for Strategic Research and Development Enter into Agreement to Evaluate IRLAB's Neuropsychiatric Programs IRL757 and IRL942

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLYGOTHENBURG, SWEDEN / ACCESSWIRE / May 16, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA); IRLAB Therapeutics

Related Keywords

Sweden ,Gothenburg ,Vastra Gotalands Lan ,Stockholm ,Arvid Carlsson ,Gewinn Nur ,Gunnar Olsson ,Mcquade Center ,Development Enter ,Strategic Research ,Nasdaq Stockholm ,Chief Executive Officer ,Nobel Laureate ,Integrative Screening Process ,Noirlab ,Herapeutics ,Mcquade ,Center ,Strategic ,Research ,Development ,Winter ,Agreement ,Valuate ,Neuropsychiatric ,Programs ,Rl757 ,Rl942 ,